Episode 13 - Dr Alex Lubansky
Podcast episode in which a scientist and medtech founder describes his ME/CFS illness, diagnosis and pacing, and his hopes for research.
Company
Melbourne, VIC
Every investor coverage indicates participated in a round Haemograph raised.
Companies Haemograph acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Dr Alex Lubansky | Chief Technical Officer · Founder | emerge.org.au, iheart.com, aprintern.org.au |
| Martina Di Venere | Research Engineer | aprintern.org.au |
Stories naming Haemograph. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Podcast episode in which a scientist and medtech founder describes his ME/CFS illness, diagnosis and pacing, and his hopes for research.
Anne Wilson interviews Dr Alex Lubansky on Emerge Australia's podcast: a chemical engineer and ME/CFS patient who founded the biomedical device firm Haemograph and is its chief technology officer.
Case study of a Deakin PhD candidate whose APR.Intern placement at a Victorian biomedical startup advanced blood-clot device R&D, leading to a full-time research engineer role.